Figure S2. related to Fig. 2. miR-128-3p expression in CRC cell lines and its effect on oxaliplatin resistance. A. Migration and invasion ability of HT29OxR cells transfected with Lv-128 and Ctrl were assessed with a Transwell assay. B. Motility ability of HT29OxR cells transfected with Lv-128 and Ctrl were assessed by wound healing assays. C. Accumulation of Pt in HT29OxR cells transfected with Lv-128 or Ctrl following exposure to 30 μM oxaliplatin treatment for 24 h. D. Total Pt-DNA adduct levels in HT29OxR cells transfected with Lv-128 or Ctrl following exposure to 30 μM oxaliplatin treatment for 24 h. E. The immunofluorescence analysis of nuclear foci for γ-H2AX expression induced by oxaliplatin in HT29OxR cells transfected with Lv-128 ...
Figure S4. MiR-133a inhibited invasion in CRC cells. (A) SW620 and HCT116 cells were transfected wit...
MiR-106b induces CRC cell resistance to irradiation. Figure S1. (A) The expression pattern of miR-1...
(a) The mRNA level of IκBα in CRC cell lines. (b) The correlation between miR-196a-5p and IκBα mRNA ...
Figure S4. related to Fig. 5. Intercellular transfer of miR-128-3p by 128-Exo sensitized CRC cells t...
Figure S7. related to Fig. 6. Exosomes containing miR-128-3p sensitized CRC cells to oxaliplatin by ...
Figure S5. related to Fig. 5. Intercellular transfer of miR-128-3p by 128-Exo sensitized CRC cells t...
Figure S3. related to Fig. 5. Intercellular transfer of miR-128-3p by 128-Exo sensitized CRC cells t...
Figure S1. related to Fig. 2. miR-128-3p expression in CRC cell lines and its effect on oxaliplatin ...
Figure S6. related to Fig. 6. Exosomes containing miR-128-3p sensitized CRC cells to oxaliplatin by ...
Table S3. Clinical characteristics of 122 CRC patients in indicated groups. (DOCX 16 kb
Table S1. Clinical characteristics of CRC patients in training phase. (DOCX 19 kb
Contains fulltext : 209046.pdf (publisher's version ) (Open Access)Most patients w...
Figure S1. (A) qRT-PCR analysis of the expression of indicated miRNAs in HCT8 and HCT116 cells. (B &...
Figure S3. TAMs derived exosomes confer drug resistance of recipient EOC cells. A2780 cells were tre...
Figure S6. Effects of SDCSC-exosomal miR-146a-5p on survival of neutrophils. (A) RT-qPCR examining e...
Figure S4. MiR-133a inhibited invasion in CRC cells. (A) SW620 and HCT116 cells were transfected wit...
MiR-106b induces CRC cell resistance to irradiation. Figure S1. (A) The expression pattern of miR-1...
(a) The mRNA level of IκBα in CRC cell lines. (b) The correlation between miR-196a-5p and IκBα mRNA ...
Figure S4. related to Fig. 5. Intercellular transfer of miR-128-3p by 128-Exo sensitized CRC cells t...
Figure S7. related to Fig. 6. Exosomes containing miR-128-3p sensitized CRC cells to oxaliplatin by ...
Figure S5. related to Fig. 5. Intercellular transfer of miR-128-3p by 128-Exo sensitized CRC cells t...
Figure S3. related to Fig. 5. Intercellular transfer of miR-128-3p by 128-Exo sensitized CRC cells t...
Figure S1. related to Fig. 2. miR-128-3p expression in CRC cell lines and its effect on oxaliplatin ...
Figure S6. related to Fig. 6. Exosomes containing miR-128-3p sensitized CRC cells to oxaliplatin by ...
Table S3. Clinical characteristics of 122 CRC patients in indicated groups. (DOCX 16 kb
Table S1. Clinical characteristics of CRC patients in training phase. (DOCX 19 kb
Contains fulltext : 209046.pdf (publisher's version ) (Open Access)Most patients w...
Figure S1. (A) qRT-PCR analysis of the expression of indicated miRNAs in HCT8 and HCT116 cells. (B &...
Figure S3. TAMs derived exosomes confer drug resistance of recipient EOC cells. A2780 cells were tre...
Figure S6. Effects of SDCSC-exosomal miR-146a-5p on survival of neutrophils. (A) RT-qPCR examining e...
Figure S4. MiR-133a inhibited invasion in CRC cells. (A) SW620 and HCT116 cells were transfected wit...
MiR-106b induces CRC cell resistance to irradiation. Figure S1. (A) The expression pattern of miR-1...
(a) The mRNA level of IκBα in CRC cell lines. (b) The correlation between miR-196a-5p and IκBα mRNA ...